Cormedix Inc (CRMD)
10.24
-0.09
(-0.87%)
USD |
NASDAQ |
Nov 22, 14:30
Cormedix Enterprise Value: 580.77M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 580.77M |
| November 20, 2024 | 605.64M |
| November 19, 2024 | 625.67M |
| November 18, 2024 | 615.96M |
| November 15, 2024 | 580.77M |
| November 14, 2024 | 621.42M |
| November 13, 2024 | 642.66M |
| November 12, 2024 | 662.07M |
| November 11, 2024 | 684.52M |
| November 08, 2024 | 657.83M |
| November 07, 2024 | 598.97M |
| November 06, 2024 | 580.16M |
| November 05, 2024 | 569.84M |
| November 04, 2024 | 535.86M |
| November 01, 2024 | 560.14M |
| October 31, 2024 | 564.08M |
| October 30, 2024 | 563.78M |
| October 29, 2024 | 740.95M |
| October 28, 2024 | 778.57M |
| October 25, 2024 | 708.82M |
| October 24, 2024 | 675.82M |
| October 23, 2024 | 668.88M |
| October 22, 2024 | 650.93M |
| October 21, 2024 | 602.31M |
| October 18, 2024 | 591.31M |
| Date | Value |
|---|---|
| October 17, 2024 | 561.21M |
| October 16, 2024 | 558.89M |
| October 15, 2024 | 538.05M |
| October 14, 2024 | 536.31M |
| October 11, 2024 | 539.79M |
| October 10, 2024 | 517.21M |
| October 09, 2024 | 528.79M |
| October 08, 2024 | 513.74M |
| October 07, 2024 | 484.80M |
| October 04, 2024 | 469.17M |
| October 03, 2024 | 433.85M |
| October 02, 2024 | 432.70M |
| October 01, 2024 | 422.86M |
| September 30, 2024 | 421.70M |
| September 27, 2024 | 419.37M |
| September 26, 2024 | 429.76M |
| September 25, 2024 | 402.62M |
| September 24, 2024 | 388.18M |
| September 23, 2024 | 362.17M |
| September 20, 2024 | 366.64M |
| September 19, 2024 | 345.97M |
| September 18, 2024 | 359.10M |
| September 17, 2024 | 357.14M |
| September 16, 2024 | 348.76M |
| September 13, 2024 | 342.62M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
33.06M
Minimum
Mar 18 2020
778.57M
Maximum
Oct 28 2024
162.55M
Average
133.36M
Median
Feb 14 2020
Enterprise Value Benchmarks
| Rockwell Medical Inc | 61.68M |
| Axogen Inc | 599.25M |
| Aquestive Therapeutics Inc | 364.60M |
| NovaBay Pharmaceuticals Inc | 2.798M |
| Palatin Technologies Inc | 15.96M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.777M |
| Revenue (Quarterly) | 11.46M |
| Total Expenses (Quarterly) | 14.74M |
| EPS Diluted (Quarterly) | -0.05 |
| Gross Profit Margin (Quarterly) | 94.01% |
| Profit Margin (Quarterly) | -24.24% |
| Earnings Yield | -7.91% |
| Normalized Earnings Yield | -7.904 |